Agah Ramtin, Chief Medical Officer of RenovoRx Inc. ($RNXT), made 12 open market purchases of company shares over the last year, totaling 161 thousand dollars. His latest buy occurred on January 21, 2026. Among nearly 5,000 insiders tracking open market buys, Ramtin ranks 1,743rd by purchase value, below the average of 1.5 million dollars across 3.3 transactions per insider. He reported no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 21, 2026 | RenovoRx, Inc. | $RNXT | Agah Ramtin | Chief Medical Officer | P | Common Stock | 10000 | $1.00 | 798,460.0000 | 36,649,916 | 1.27% | 0.03% |
| Dec. 31, 2025 | RenovoRx, Inc. | $RNXT | Agah Ramtin | Chief Medical Officer | P | Common Stock | 9795 | $0.86 | 788,460.0000 | 36,649,916 | 1.26% | 0.03% |
| Dec. 30, 2025 | RenovoRx, Inc. | $RNXT | Agah Ramtin | Chief Medical Officer | P | Common Stock | 205 | $0.83 | 778,665.0000 | 36,649,916 | 0.03% | 0.00% |
| Dec. 16, 2025 | RenovoRx, Inc. | $RNXT | Agah Ramtin | Chief Medical Officer | P | Common Stock | 12000 | $0.85 | 778,460.0000 | 36,649,916 | 1.57% | 0.03% |
| Dec. 5, 2025 | RenovoRx, Inc. | $RNXT | Agah Ramtin | Chief Medical Officer | P | Common Stock | 10000 | $0.96 | 766,460.0000 | 36,649,916 | 1.32% | 0.03% |
| Nov. 21, 2025 | RenovoRx, Inc. | $RNXT | Agah Ramtin | Chief Medical Officer | P | Common Stock | 10000 | $0.80 | 744,460.0000 | 36,649,916 | 1.36% | 0.03% |
| Nov. 24, 2025 | RenovoRx, Inc. | $RNXT | Agah Ramtin | Chief Medical Officer | P | Common Stock | 12000 | $0.80 | 756,460.0000 | 36,649,916 | 1.61% | 0.03% |
| July 1, 2025 | RenovoRx, Inc. | $RNXT | Agah Ramtin | Chief Medical Officer | A | Stock Option | 63636 | $0.00 | 63,636.0000 | 36,546,752 | 9999.99% | 0.17% |
| June 5, 2025 | RenovoRx, Inc. | $RNXT | Agah Ramtin | Chief Medical Officer | P | Common Stock | 21000 | $1.40 | 734,460.0000 | 36,546,752 | 2.94% | 0.06% |
| April 22, 2025 | RenovoRx, Inc. | $RNXT | Agah Ramtin | Chief Medical Officer | G | Common Stock | 400000 | $0.00 | 713,460.0000 | 36,546,752 | 35.92% | 1.09% |
| April 15, 2025 | RenovoRx, Inc. | $RNXT | Agah Ramtin | Chief Medical Officer | P | Common Stock | 15000 | $0.90 | 1,113,460.0000 | 36,546,752 | 1.37% | 0.04% |
| April 14, 2025 | RenovoRx, Inc. | $RNXT | Agah Ramtin | Chief Medical Officer | A | Stock Option | 254542 | $0.00 | 254,542.0000 | 36,546,752 | 9999.99% | 0.70% |
| April 11, 2025 | RenovoRx, Inc. | $RNXT | Agah Ramtin | Chief Medical Officer | P | Common Stock | 20000 | $0.80 | 1,098,460.0000 | 36,546,752 | 1.85% | 0.05% |
| April 9, 2025 | RenovoRx, Inc. | $RNXT | Agah Ramtin | Chief Medical Officer | P | Common Stock | 30000 | $0.81 | 1,078,460.0000 | 36,546,752 | 2.86% | 0.08% |
| April 8, 2025 | RenovoRx, Inc. | $RNXT | Agah Ramtin | Chief Medical Officer | P | Common Stock | 26000 | $0.84 | 1,048,460.0000 | 36,546,752 | 2.54% | 0.07% |
| Jan. 26, 2024 | RenovoRx, Inc. | $RNXT | Agah Ramtin | Chief Medical Officer | P | Common Stock | 40983 | $0.00 | 47,460.0000 | 0 | 632.75% | 0.00% |
| Jan. 26, 2024 | RenovoRx, Inc. | $RNXT | Agah Ramtin | Chief Medical Officer | P | Warrants | 40983 | $0.00 | 40,983.0000 | 0 | 9999.99% | 0.00% |
| Jan. 19, 2024 | RenovoRx, Inc. | $RNXT | Agah Ramtin | Chief Medical Officer | A | Stock Option | 125132 | $0.00 | 125,132.0000 | 0 | 9999.99% | 0.00% |
| Jan. 19, 2024 | RenovoRx, Inc. | $RNXT | Agah Ramtin | Chief Medical Officer | A | Stock Option | 28424 | $0.00 | 28,424.0000 | 0 | 9999.99% | 0.00% |